Blog
    Peptide SpotlightFor PatientsMay 17, 2026

    Do all peptides work? Evidence for popular compounds

    Learn which peptides like Semaglutide and Tirzepatide have FDA approval and clinical evidence, versus those still in trial phases or showing side effects.

    Look, I know what the internet told you. There is this idea floating around that if it ends in "-tide," it is a scientifically proven miracle. While peptides are fascinating, the truth is a bit more complicated. Some have decades of gold-standard data, while others are still in the "we hope this works" phase.

    The Heavy Hitters (FDA Approved)

    Not every peptide is equal. Some have gone through the absolute ringer of clinical trials. Take Semaglutide and Tirzepatide, which both have an A+ Evidence Grade.

    Semaglutide is 94% similar to your body's natural GLP-1 hormone. It works by signaling your brain to reduce appetite and slowing down how fast your stomach empties. In the STEP 1 trial, it showed a 14.9% weight loss. Tirzepatide goes a step further by targeting two receptors (GLP-1 and GIP) at once, showing a 22.5% weight loss in the SURMOUNT-1 study.

    Then there is Tesamorelin. It is FDA-approved specifically for HIV-associated lipodystrophy, which is a fancy way of saying it helps reduce deep belly fat (visceral fat) by 18%. However, if you stop taking it, the effects completely reverse. That is a pretty important detail to mention before you start, right?

    The "In-Betweeners"

    Some peptides are well-studied but stuck in a weird legal or scientific limbo.

    • Thymosin Alpha-1: This one has an A- Grade and is approved in over 35 countries. It helps your immune system mature its defensive T-cells. But here is the catch: it is NOT FDA-approved in the U.S., and scientists are still figuring out the best doses for things like anti-aging.
    • Retatrutide: This is the new "triple threat" that targets three different receptors. It showed a massive 24.2% weight loss in Phase II trials, but it only has a B+ Grade because those were small studies. We are still waiting on Phase III results to see if the side effects are worth it.

    The "Not Actually a Peptide" Imposter

    Then we have MK-677 (Ibutamoren). Funny thing: it isn't even a peptide in the strict scientific sense. It is a small-molecule drug that mimics ghrelin to increase growth hormone. It has a B Grade because while it can help with muscle mass, it also raises your fasting blood sugar and failed its trials for Alzheimer's.

    The Reality Check

    Even the best peptides have trade-offs. For example, Semaglutide has over 187,000 adverse event reports. Common issues include:

    • Nausea (affecting 44% of people)
    • Vomiting
    • Delayed gastric emptying (your stomach clears out slower)
    • Weight regain if you stop taking it

    Scientists are still working on these issues—turns out the human body is complicated. Who knew?

    This is a great one to bring up with your doctor. You can find peptide-experienced physicians in our Find a Doctor directory.

    This content is sourced exclusively from TruthTides clinical reference data and does not constitute medical advice.

    This content was generated from TruthTides clinical reference data. It does not constitute medical advice. Always consult a qualified healthcare provider.